These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6290119)

  • 1. Methylaplysinopsin: a natural product of marine origin with effects on serotonergic neurotransmission.
    Baird-Lambert J; Davis PA; Taylor KM
    Clin Exp Pharmacol Physiol; 1982; 9(2):203-12. PubMed ID: 6290119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylaplysinopsin and other marine natural products affecting neurotransmission.
    Taylor KM; Baird-Lambert JA; Davis PA; Spence I
    Fed Proc; 1981 Jan; 40(1):15-20. PubMed ID: 6256214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms.
    Chung Hwang E; Van Woert MH
    J Pharmacol Exp Ther; 1980 May; 213(2):254-60. PubMed ID: 6965983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. McN-5652: a highly potent inhibitor of serotonin uptake.
    Shank RP; Vaught JL; Pelley KA; Setler PE; McComsey DF; Maryanoff BE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1032-8. PubMed ID: 2905001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.
    Hensler JG; Kovachich GB; Frazer A
    Neuropsychopharmacology; 1991 Feb; 4(2):131-44. PubMed ID: 2025379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic modulation of neurotransmission in the rat subicular cortex in vitro: a role for 5-HT1B receptors.
    Boeijinga PH; Boddeke HW
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):553-7. PubMed ID: 8133898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.